Latest Strategic Partnerships News

Nuchev Limited reports a record-breaking Q4 FY25 with revenues soaring 167% year-on-year, driven by strong growth across multiple markets and a strategic agency agreement in Australia.

Gold Hydrogen Limited has locked in a $14.5 million strategic investment from major Japanese corporations to fund expanded drilling and appraisal at its Ramsay Project in South Australia. This capital injection aims to advance the company’s pioneering work in Natural Hydrogen and Helium exploration.

Tivan Limited has forged binding joint ventures with Sumitomo Corporation and JOGMEC, secured significant equity investments, and launched a major drilling campaign to advance its Speewah Fluorite Project in Western Australia.

European Lithium has sold 0.5 million shares of Critical Metals Corp to a US institutional investor for approximately US$1.8 million, underscoring the significant value of its remaining stake.

Titomic has launched a major US manufacturing hub in Alabama, secured key defense contracts, and expanded leadership to accelerate its global additive manufacturing ambitions.

Nova Minerals' board recently toured the Estelle Gold and Critical Minerals Project in Alaska, receiving robust support from federal, state, and tribal leaders as the company moves closer to production.

AML3D Limited reports a 77% jump in US customer receipts and secures a pivotal US Navy Letter of Intent worth up to $200 million, underpinning its rapid expansion in defence manufacturing.

Gibb River Diamonds has commenced grade control drilling at its Neta Prospect in Western Australia, moving closer to potential mining operations pending regulatory approval.

Orange Minerals NL has raised $810,000 to fund exploration and due diligence on its new Tepa Gold Project acquisition in Ghana, while advancing promising Australian projects with notable assay results.

EQ Resources Limited highlighted its growing global footprint in tungsten mining at the 2025 Noosa Mining Conference, detailing production growth, reserve expansions, and strategic funding initiatives.

Island Pharmaceuticals reported promising Phase 2a/b trial results for its dengue drug ISLA-101 and secured a strategic acquisition of the broad-spectrum antiviral Galidesivir, bolstering its pipeline and balance sheet.

Red Mountain Mining has partnered with Canadian exploration experts Fladgate to advance its Fry Lake Gold Project, while seeking Ontario government funding to offset exploration costs.